BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16445711)

  • 1. Meta-analysis of the differences in the time to onset of action between rocuronium and vecuronium.
    Nava-Ocampo AA; Velázquez-Armenta Y; Moyao-García D; Salmerón J
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):125-30. PubMed ID: 16445711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable designs of clinical trials of neuromuscular blocking agents: an example of studies comparing rocuronium and vecuronium.
    Nava-Ocampo AA; Velázquez-Armenta Y; Moyao-García D; Antonio-Ocampo A; Salmerón J
    Med Sci Monit; 2005 Feb; 11(2):PI22-30. PubMed ID: 15668623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming rapacuronium: a comparison with rocuronium and mivacurium.
    Steinberg D
    Acta Cient Venez; 2003; 54(2):115-20. PubMed ID: 14976782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure.
    Della Rocca G; Pompei L; Coccia C; Costa MG; Cecchini V; Vilardi V; Pietropaoli P
    Minerva Anestesiol; 2003; 69(7-8):605-11, 612, 5. PubMed ID: 14564242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.
    Kim DW; Joshi GP; White PF; Johnson ER
    Anesth Analg; 1996 Oct; 83(4):818-22. PubMed ID: 8831328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priming studies with rocuronium and vecuronium.
    Redai I; Feldman SA
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():11-3. PubMed ID: 8556997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of rocuronium and vecuronium: the pharmacodynamic, cardiovascular and intra-ocular effects.
    Robertson EN; Hull JM; Verbeek AM; Booij LH
    Eur J Anaesthesiol Suppl; 1994; 9():116-21. PubMed ID: 7925202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sedation after intubation using etomidate and a long-acting neuromuscular blocker.
    Kendrick DB; Monroe KW; Bernard DW; Tofil NM
    Pediatr Emerg Care; 2009 Jun; 25(6):393-6. PubMed ID: 19458564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of rocuronium bromide in hepatic cirrhosis.
    Hunter JM
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():39-41. PubMed ID: 8557004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response relationship and time course of action of rocuronium bromide in perspective.
    Viby-Mogensen J
    Eur J Anaesthesiol Suppl; 1994; 9():28-32. PubMed ID: 7925205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intubating conditions and onset of action after rocuronium, vecuronium, and atracurium in young children.
    Scheiber G; Ribeiro FC; Marichal A; Bredendiek M; Renzing K
    Anesth Analg; 1996 Aug; 83(2):320-4. PubMed ID: 8694312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intubation conditions and time-course of action of low-dose rocuronium bromide in day-case dental surgery.
    Pollard BJ; Chetty MS; Wilson A; Healy TE
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():81-3. PubMed ID: 8557013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacoeconomic analysis of neuromuscular blocking agents in the operating room.
    Loughlin KA; Weingarten CM; Nagelhout J; Stevenson JG
    Pharmacotherapy; 1996; 16(5):942-50. PubMed ID: 8888091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the pharmacodynamics of rocuronium and vecuronium during halothane anaesthesia.
    Booth MG; Marsh B; Bryden FM; Robertson EN; Baird WL
    Anaesthesia; 1992 Oct; 47(10):832-4. PubMed ID: 1359803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular pharmacodynamics of rocuronium in patients with major burns.
    Han T; Kim H; Bae J; Kim K; Martyn JA
    Anesth Analg; 2004 Aug; 99(2):386-92, table of contents. PubMed ID: 15271712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response and time-course of action of rocuronium bromide.
    Mirakhur RK
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():23-5. PubMed ID: 8557001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuromuscular blocking effects of Org 9426 (rocuronium bromide); a comparative study with vecuronium bromide in Japanese patients].
    Shingu K; Masuzawa M; Omote K; Namiki A; Kikuchi H; Kawamada M; Sato S; Kimura T; Hatano N; Nakatsuka H; Morita K; Hara T; Kanmura Y; Takeda J
    Masui; 2006 Sep; 55(9):1140-8. PubMed ID: 16984012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in myorelaxant therapy.
    Meakin GH
    Paediatr Anaesth; 2001; 11(5):523-31. PubMed ID: 11696115
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacokinetic/dynamic relationship of rocuronium bromide in humans.
    Wierda JM; Proost JH; Schiere S; Hommes FD
    Eur J Anaesthesiol Suppl; 1994; 9():66-74. PubMed ID: 7925212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.